Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

Gane, E; Lawitz, E; Pugatch, D; Papatheodoridis, G; Brau, N; Brown, A; Pol, S; Leroy, V; Persico, M; Moreno, C; Colombo, M; Yoshida, EM; Nelson, DR; Collins, C; Lei, Y; Kosloski, M; Mensa, FJ

Gane, E (reprint author), Auckland City Hosp, 2 Pk Rd, Auckland 1023, New Zealand.

NEW ENGLAND JOURNAL OF MEDICINE, 2017; 377 (15): 1448

Abstract

BACKGROUND Chronic hepatitis C virus (HCV) infection is more prevalent among patients who have chronic kidney disease than among those who do not have......

Full Text Link